drugset / Trial / NCT05515887

Influence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional Dyspepsia

NCT05515887 ↗

Phase 4 Completed 50 enrolled Ruijin Hospital
NaSingle-groupOpen-labelTreatment

Summary

It has been confirmed that treatment with Shenqu Xiaoshi Oral liquid (SXOL) effectively improves dyspeptic symptoms and is well tolerated. It is not inferior to domperidone syrup and leads to sustained improvement in Chinese children with functional dyspepsia (FD). This study aims to evaluate the possible regulatory effect of SXOL on intestinal microbiome in children with FD, further exploring its related mechanism.

Timeline

Start
2022-11-22
Primary completion
2024-12-31
Completion
2025-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Shenqu Xiaoshi Oral liquid Unknown 5 ml Oral
Subject Shenqu Xiaoshi Oral liquid Unknown 10 ml Oral

Indications